RVP Stock Overview
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Retractable Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.06 |
| 52 Week High | US$1.85 |
| 52 Week Low | US$0.95 |
| Beta | 2.1 |
| 1 Month Change | -10.17% |
| 3 Month Change | -13.80% |
| 1 Year Change | -39.27% |
| 3 Year Change | -89.34% |
| 5 Year Change | 41.81% |
| Change since IPO | -91.69% |
Recent News & Updates
Recent updates
Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?
Mar 16
Do Insiders Own Lots Of Shares In Retractable Technologies, Inc. (NYSEMKT:RVP)?
Feb 26Retractable Technologies (NYSEMKT:RVP) Knows How To Allocate Capital Effectively
Feb 08Here's Why I Think Retractable Technologies (NYSEMKT:RVP) Might Deserve Your Attention Today
Jan 12
Here's Why We Don't Think Retractable Technologies's (NYSEMKT:RVP) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 28Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?
Dec 14How Should Investors React To Retractable Technologies' (NYSEMKT:RVP) CEO Pay?
Dec 01Shareholder Returns
| RVP | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.0% | 1.6% | 1.0% |
| 1Y | -39.3% | -1.4% | 21.9% |
Price Volatility
| RVP volatility | |
|---|---|
| RVP Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RVP's share price has been volatile over the past 3 months.
Volatility Over Time: RVP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 150 | Thomas Shaw | www.retractable.com |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network.
Retractable Technologies, Inc. Fundamentals Summary
| RVP fundamental statistics | |
|---|---|
| Market cap | US$31.73m |
| Earnings (TTM) | -US$7.24m |
| Revenue (TTM) | US$43.60m |
0.7x
P/S Ratio-4.4x
P/E RatioIs RVP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVP income statement (TTM) | |
|---|---|
| Revenue | US$43.60m |
| Cost of Revenue | US$34.49m |
| Gross Profit | US$9.11m |
| Other Expenses | US$16.35m |
| Earnings | -US$7.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 20.89% |
| Net Profit Margin | -16.61% |
| Debt/Equity Ratio | 1.5% |
How did RVP perform over the long term?
See historical performance and comparison